GENENTECH's PROTROPIN MARKETING EXCLUSIVITY COVERS SECOND GENERATION RECOMBINANT hGH, FIRM ARGUES; TWO GENERATIONS ARE "CLINICALLY EQUIVALENT"

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".